Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L17 pseudogene 1 (RPL17P1)
- Target
- RPL17P1
- Molecular classification
- Other, Pseudogene
01
Overview
Ribosomal protein L17 pseudogene 1 (RPL17P1) is a **pseudogene** related to the ribosomal protein L17 gene, which encodes a component of the large 60S ribosomal subunit[1][4][7][15]. Pseudogenes like RPL17P1 are genomic elements that resemble known genes but are considered *non-functional;* they arise from duplication or retrotransposition events and typically do not produce functional proteins[3][5]. While emerging research suggests some pseudogenes may have regulatory RNA functions, there is currently no evidence that RPL17P1 plays a direct biological role or is involved in diseases[3][5]. It does not serve as a recognized therapeutic target, biomarker, or direct diagnostic indicator. The official symbols, synonyms, and product listings confirm its status as a non-coding pseudogene[15]. If you are seeking information on ribosomal protein L17 itself—a true component of the ribosome with known cellular roles—refer to **RPL17** (not RPL17P1)[1][4][7][13][17].
- Other names
- dJ1178H5.1RPL17_18_1690RPL17P1
02
Mechanism of action
None (no drugs target this pseudogene)
03
Biological functions
Other (no known direct biological function; pseudogenes are generally considered non-functional, though some may play regulatory roles at the RNA level[3][5])
04
Disease associations
Other (no confirmed disease association specific to RPL17P1)
05
Safety considerations
None
06
Interacting drugs
None (no known drugs interact with pseudogenes, and RPL17P1 does not encode a functional protein[3][5][15])
07
Biomarkers
None
Beyond the preview
Go deeper on Ribosomal protein L17 pseudogene 1 (RPL17P1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ribosomal protein L17 pseudogene 1 (RPL17P1).